SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-006310
Filing Date
2018-06-05
Accepted
2018-06-05 16:45:46
Documents
4
Period of Report
2018-06-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tenx_8k.htm 8-K 31906
2 EMPLOYMENT AGREEMENT WITH ANTHONY A. DITONNO tenx_ex101.htm EX-10.1 176437
3 PRESS RELEASE tenx_ex991.htm EX-99.1 12925
4 IMAGE img001.jpg GRAPHIC 6847
  Complete submission text file 0001654954-18-006310.txt   232402
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 18881736
SIC: 8731 Services-Commercial Physical & Biological Research